Atrinsic Inc. (NASDAQ:PTIX – Get Free Report)’s stock price rose 14.5% during mid-day trading on Tuesday . The company traded as high as $0.21 and last traded at $0.21. Atrinsic Stock Down 15.0%The firm has a fifty day moving average of $0.34 and a 200-day moving average of $0.48. Atrinsic Company Profile(Get Free Report)Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Further ReadingReceive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.